Selective H1-receptor antagonist and mast cell stabilizer

This page covers all Selective H1-receptor antagonist and mast cell stabilizer drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting H1 receptor; mast cell stabilization, H1 histamine receptor.

Targets

H1 receptor; mast cell stabilization · H1 histamine receptor

Marketed (1)

• Olopatadine 0.1% · Bausch & Lomb Incorporated · Ophthalmology/Allergy
  Olopatadine is a selective H1-receptor antagonist and mast cell stabilizer that reduces allergic inflammation in the eye.

Phase 3 pipeline (1)

• Rescue Medication: Olopatadine ophthalmic drops · ALK-Abelló A/S · Ophthalmology / Allergy
  Olopatadine is a selective H1-receptor antagonist and mast cell stabilizer that blocks histamine-mediated allergic responses in the eye.

Patent intelligence

• selective h1 receptor antagonist and mast cell stabilizer patent landscape — aggregated cliff calendar, attackable patents, originator estates